IDEXX Laboratories, Inc.
IDXX Healthcare Diagnostics & Research
IDEXX Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 10.4% from fiscal 2024.
- Revenue
- +9.86%
- EPS
- +17.3%
- Free cash flow
- +17.6%
- Total debt
- −28.6%
Quarter to September 2026, against a year earlier
Follow IDXX
Alert me
IDEXX Laboratories, Inc. (IDXX) Gross margin
IDEXX Laboratories, Inc.'s gross margin over the twelve months to 30 September 2026 was 62.7%, up 0.9 percentage points from fiscal 2025 (61.8%). Over the past ten years it has ranged from 54.9% (fiscal 2016) to 61.8% (fiscal 2025) — the current reading is the highest in ten years. That is above the Diagnostics & Research industry median of 48.3% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 61.8% | 0.76 |
| FY2024 | 61.0% | 1.22 |
| FY2023 | 59.8% | 0.30 |
| FY2022 | 59.5% | 0.76 |
| FY2021 | 58.8% | 0.72 |
| FY2020 | 58.0% | 1.31 |
| FY2019 | 56.7% | 0.63 |
| FY2018 | 56.1% | 0.37 |
| FY2017 | 55.7% | 0.79 |
| FY2016 | 54.9% | (0.64) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 62.9% | (1.10) |
| Jun 2026 | 64.0% | 0.69 |
| Mar 2026 | 63.4% | 3.00 |
| Dec 2025 | 60.4% | (1.48) |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| ILMN Illumina, Inc. compare | 67.9% |
| IDXX IDEXX Laboratories, Inc. | 62.7% |
| MTD Mettler-Toledo International, Inc. compare | 60.3% |
| A Agilent Technologies, Inc. compare | 53.8% |
| WAT Waters Corporation compare | 49.5% |
| DGX Quest Diagnostics Incorporated compare | 33.1% |
| IQV IQVIA Holdings Inc. compare | 33.1% |
| LH Labcorp Holdings Inc. compare | 29.0% |
| NTRA Natera, Inc. compare | 0.00% |
| Diagnostics & Research industry median | 48.3% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on IDXX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement